16-076
Showing 101 - 125 of 5,477
Phenylketonurias Trial in Milan (GOLIKE PLUS 3-16, Free AAs)
Recruiting
- Phenylketonurias
- GOLIKE PLUS 3-16
- Free AAs
-
Milan, ItalySan Paolo Hospital
Jan 30, 2023
Carcinoma Breast Stage IV Trial in United States (Pembrolizumab, Carboplatin, Gemcitabine)
Recruiting
- Carcinoma Breast Stage IV
- Pembrolizumab
- +2 more
-
Indianapolis, Indiana
- +5 more
Nov 16, 2021
Phenylketonurias Trial (PKU GOLIKE)
Not yet recruiting
- Phenylketonurias
- PKU GOLIKE
- (no location specified)
Apr 12, 2023
Preterm Birth Trial in Valencia (Clorhexidine)
Completed
- Preterm Birth
- Clorhexidine
-
Valencia, SpainHospital Uiversitario y Politécnico La Fe
Jul 5, 2023
MDD Trial in Ames (Resistance Exercise Training)
Active, not recruiting
- Major Depressive Disorder
- Resistance Exercise Training
-
Ames, IowaIowa State University
Jan 12, 2023
Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders (Including Diabetes) Trial in Canada (Support-t)
Not yet recruiting
- Diabetes Mellitus
- +6 more
- Support-t
-
Gatineau, Canada
- +3 more
Jun 16, 2023
Peripheral Nerve Injuries Trial in United States (NTX-001)
Recruiting
- Peripheral Nerve Injuries
- NTX-001
-
Aurora, Colorado
- +11 more
Jan 3, 2023
HEAD & NECK Cancer Trial in New York (ribavirin)
Active, not recruiting
- HEAD & NECK Cancer
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 11, 2023
Responsiveness of the Object Permanence Scale
Recruiting
- Developmental Delay
-
Tokat, TurkeyFaculty of Health Sciences, Tokat Gaziosmanpaşa University
Feb 19, 2023
The PIPAC PET Pilot Study, OPC-7
Not yet recruiting
- Peritoneal Cancer
- +3 more
- scan
- (no location specified)
Nov 17, 2023
Iron Deficiency, Anaemia in Children Trial in Phattalung (Dietary Iron Program)
Completed
- Iron Deficiency, Anaemia in Children
- Dietary Iron Program
-
Phattalung, Phattalung Province, ThailandMs Witchada Simla
May 18, 2023
Xolair® in Pediatric Chronic Spontaneous Urticaria in China
Not yet recruiting
- Chronic Spontaneous Urticaria
- Xolair
- (no location specified)
Sep 19, 2023
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +172 more
Jan 23, 2023
Healthcare Providers, Health-Related Behavior, Exercise Trial in Zonguldak (mat pilates)
Completed
- Healthcare Providers
- +2 more
- mat pilates
-
Zonguldak, Kozlu, TurkeyZonguldak Bülent Ecevit University
Oct 7, 2022
Obesity Trial (Usual care, SELF, STEP)
Not yet recruiting
- Obesity
- Usual care
- +2 more
- (no location specified)
Nov 21, 2023
Covid19 Trial in San Mateo, Stanford (Filtration Fan, Safe-home pamphlet, Mid-week phone call)
Enrolling by invitation
- Covid19
- Filtration Fan
- +2 more
-
San Mateo, California
- +1 more
Mar 18, 2023
Pregnancy Related, Adolescent Behavior, Sexually Transmitted Diseases Trial in Berkeley (Next4You)
Enrolling by invitation
- Pregnancy Related
- +2 more
- Next4You
-
Berkeley, CaliforniaRTI
Nov 7, 2023
Glabellar Frown Lines Trial (PROTOXIN)
Not yet recruiting
- Glabellar Frown Lines
- PROTOXIN
- (no location specified)
Nov 8, 2023
Trauma-Sensitive Mindfulness and Compassion Intervention
Completed
- Complex Post-Traumatic Stress Disorder
- TMC Treatment Approach
-
Vikersund, NorwayModum Bad
Aug 16, 2023
HIV/AIDS, Young Adult, Mobile Health Trial in San Francisco (Standard of Care, Video-counseling+app)
Not yet recruiting
- HIV/AIDS
- +4 more
- Standard of Care
- Video-counseling+app
-
San Francisco, CaliforniaDivision of Prevention Science, Center for AIDS Prevention Studi
May 17, 2023
Contact Lens, Astigmatism of Both Eyes Trial in Columbus (Precision1® Daily Disposable Toric Contact Lens)
Active, not recruiting
- Contact Lens
- Astigmatism of Both Eyes
- Precision1® Daily Disposable Toric Contact Lens
-
Columbus, OhioThe Ohio State University
Oct 13, 2022
Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Completed
- Human Papillomavirus Infection
- Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
- Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
-
Nanjing, Jiangsu, ChinaCDC, Jiangsu Province
Jan 12, 2023